Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juli 2022

Genmab — Juli 2022

Planlagt Fastgjort Låst Flyttet Genmab
808 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #149

    USA/lukning: Teknologiaktierne sikrede små smil efter hård start https://www.proinvestor.com/investornyt/846340/usa-lukning-teknologiaktierne-sikrede-sma-smil-efter-hard-start

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #150

      God morgen. 🙂

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #151

        God morgen. 🙂

        1 Reply Last reply
        0
        • S Offline
          S Offline
          Stroka
          wrote on sidst redigeret af
          #152

          God morgen. 🙂

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #153

            Asien: Kursfald grundet stigende frygt for global recession https://www.proinvestor.com/investornyt/846457/asien-kursfald-grundet-stigende-frygt-for-global-recession

            1 Reply Last reply
            0
            • P Offline
              P Offline
              ProinvestorNEWS
              wrote on sidst redigeret af
              #154

              Onsdagens aviser med SAS, Novo Nordisk og Leo Pharma https://www.proinvestor.com/investornyt/846456/onsdagens-aviser-med-sas-novo-nordisk-og-leo-pharma

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #155

                Copenhagen Compounder
                @cphcompounder/Twitter
                ·$XBI er oppe 17% siden den bund i Maj som også var bunden i ‘18 og ‘20. Den lavere rente pga frygt for recession sender lige nu investorerne ud af ‘value’ og tilbage ind i bl.a. biotech - og tror først lige den bevægelse er startet. https://twitter.com/cphcompounder/status/1544550148788944896

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #156

                  Betydeligt større omsætning end de foregående dage. 22k på 20 min.

                  1 Reply Last reply
                  0
                  • M Offline
                    M Offline
                    Monforte
                    wrote on sidst redigeret af
                    #157

                    @Bikube 5/7 kl 15:52. Tak for din opmærksomhed. Der er ikke de store ændringer. DARA virker stadig upåklageligt efter 104 sekvenser.

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #158

                      Det er vi mange der er glade for at høre;-)

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #159

                        Abstract LB087: Characterization of JNJ-70218902, a TMEFF2 x CD3 bispecific antibody, in prostate cancer models https://aacrjournals.org/cancerres/article/82/12_Supplement/LB087/703769

                        1 Reply Last reply
                        0
                        • B Offline
                          B Offline
                          bikube
                          wrote on sidst redigeret af
                          #160

                          Monforte - Dejligt at høre. Som jeg har sagt før, så må folk finde på noget andet at dø af.

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #161

                            this Mim8 safety trial completed
                            https://clinicaltrials.gov/ct2/history/NCT05127473?A=5&B=6&C=merged#StudyPageTop

                            1 Reply Last reply
                            0
                            • H Offline
                              H Offline
                              Hamming
                              wrote on sidst redigeret af
                              #162

                              Oversigt over bispecifikke i prostata kræft: https://www.targetedonc.com/view/advancing-t-cell-redirecting-agents-in-prostate-cancer

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #163

                                and this one is interesting; was set to Active, not recruiting , last november, at 101 [Actual] enrolled; now it appears the date is extended and suddenly 275 have enrolled https://clinicaltrials.gov/ct2/history/NCT04204408?A=46&B=47&C=merged#StudyPageTop

                                1 Reply Last reply
                                0
                                • H Offline
                                  H Offline
                                  Hamming
                                  wrote on sidst redigeret af
                                  #164

                                  Inclacumab har fået orphan drug + rare pediatric disease designation https://www.hcplive.com/view/fda-sickle-cell-treatments-orphan-drug-status

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    bikube
                                    wrote on sidst redigeret af
                                    #165

                                    Jeg bemærker lige, at de stadig sælger nye aktier for warrants, de har da ellers nok aktier på lager at tage af.

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #166

                                      that's nice! good find Hamming!

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #167

                                        we may hear a bit more on Mim8 from Novo next month -Novo Nordisk announces innovation plans in rare blood disorders’ treatment- https://www.financialexpress.com/healthcare/pharma-healthcare/novo-nordisk-announces-innovation-plans-in-rare-blood-disorders-treatment/2577047/

                                        1 Reply Last reply
                                        0
                                        • B Offline
                                          B Offline
                                          bikube
                                          wrote on sidst redigeret af
                                          #168

                                          Angående dagens kursudvikling - skal vi mon ned og lukke gapet fra i morges ?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper